MAZE - CIK 0001842295
Maze Therapeutics, Inc. has filed 165 documents with the SEC between 2024 and 2026. The most frequent type is insider trade (52 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2026-05-27 | 2026-05-22 |
| Major company event | 8-K | 2026-05-22 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 | 2026-05-14 |
| Insider trade | 4 | 2026-05-18 | 2026-05-15 |
| Insider sale notice | 144 | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| EFFECT | - | 2026-05-13 | - |
| Quarterly report | 10-Q | 2026-05-12 | 2026-03-31 |
| Major company event | 8-K | 2026-05-12 | 2026-05-12 |
| POS AM | - | 2026-05-12 | - |
| Insider trade | 4 | 2026-05-06 | 2026-05-04 |
| Insider trade | 4 | 2026-05-06 | 2026-05-04 |
| Insider trade | 4 | 2026-05-01 | 2026-04-29 |
| Annual report to shareholders | ARS | 2026-04-28 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-28 | - |
| Proxy statement | DEF 14A | 2026-04-28 | 2026-06-08 |
| Major company event | 8-K | 2026-04-22 | 2026-04-21 |
| Prospectus supplement | 424B5 | 2026-04-22 | - |
| Insider trade | 4 | 2026-04-02 | 2026-04-01 |
| Insider trade | 4 | 2026-04-02 | 2026-04-01 |
| Insider trade | 4 | 2026-04-01 | 2026-03-30 |
| SCHEDULE 13G | - | 2026-04-01 | - |
| Insider trade | 4 | 2026-03-31 | 2026-03-27 |
| New insider ownership | 3 | 2026-03-31 | 2026-03-27 |
| Insider sale notice | 144 | 2026-03-30 | - |
| Annual report | 10-K | 2026-03-25 | 2025-12-31 |
| Major company event | 8-K | 2026-03-25 | 2026-03-24 |
| Insider trade | 4 | 2026-03-20 | 2026-03-20 |
| Insider trade | 4 | 2026-03-12 | 2026-03-10 |
| Insider sale notice | 144 | 2026-03-10 | - |
| Insider trade | 4 | 2026-03-03 | 2026-03-02 |
| Insider trade | 4 | 2026-03-03 | 2026-03-02 |
| Insider trade | 4 | 2026-03-03 | 2026-02-27 |
| Insider trade | 4 | 2026-03-03 | 2026-03-02 |
| Insider trade | 4 | 2026-03-03 | 2026-03-02 |
| Insider trade | 4 | 2026-03-03 | 2026-03-02 |
| SCHEDULE 13G/A | - | 2026-02-13 | - |
| SCHEDULE 13G/A | - | 2026-02-13 | - |
| SCHEDULE 13G/A | - | 2026-02-06 | - |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-04 | 2026-02-02 |
| Employee stock plan | S-8 | 2026-02-04 | - |
| S-3ASR | - | 2026-02-04 | - |
| Major company event | 8-K | 2026-02-04 | 2026-02-02 |
| Insider trade | 4 | 2026-02-02 | 2026-01-29 |
| Insider trade | 4 | 2026-01-26 | 2026-01-22 |
| Insider sale notice | 144 | 2026-01-16 | - |
| Insider trade | 4 | 2026-01-09 | 2026-01-07 |
| Insider trade | 4 | 2026-01-08 | 2026-01-06 |
| Insider sale notice | 144 | 2026-01-07 | - |